Detection of EGFR activating and T790M resistance mutations in plasma of lung cancer patients using combined exosomal RNA and cfDNA capture.

e22156 Background: Initial response to tyrosine kinase inhibitors (TKIs) in NSCLC patients with EGFR activating mutations are commonly observed, however patients inevitably progress as a consequenc...